EM-T3Pharmacoepidemiology and Drug Safety2024-09-01第 33 卷第 9 期，e70007-e70007开放获取高影响力 · 前 10%
PMDA Perspective on RWD / RWE Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage
